NVALT28, NCT04597671: Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC |
|
|
| Recruiting | 3 | 170 | Europe | Durvalumab, Imfinzi, low-dose PCI, Prophylactic Cranial Irradiation (PCI) | Association NVALT Studies | Carcinoma, Non-Small-Cell Lung | 12/28 | 12/32 | | |
ELDAPT, NCT02284308: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy |
|
|
| Recruiting | N/A | 288 | Europe | Blood withdrawal | Maastricht Radiation Oncology, Dutch Society of Physicians for Pulmonology and Tuberculosis, Erasmus Medical Center, VieCuri Medical Centre, AstraZeneca, Dutch Cancer Society | NSCLC | 07/24 | 07/25 | | |
